Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

2.60
Delayed Data
As of 4:00pm ET
 -0.05 / -1.89%
Today’s Change
2.13
Today|||52-Week Range
10.18
-70.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues12.7M19.6M7.7M20.8M
 
 
 
 
 
Depreciation And Amortization1.0M1.4M1.5M1.6M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses24.3M36.0M51.1M73.9M
 
 
 
 
 
Research And Development20.3M29.9M41.0M56.4M
 
 
 
 
 
Total Operating Expenses25.3M37.4M52.6M75.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.6M-17.8M-44.9M-54.8M
 
 
 
 
 
Extraordinary Charge-4.7M-1.1M-12.1M-1.8M
 
 
 
 
 
Interest Expense On Debt247.0K36.0K39.0K52.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.4M-18.7M-56.7M-55.8M
 
 
 
 
 
Income Taxes-10.0K-23.0K-1.0K-18.0K
 
 
 
 
 
Net Income-17.4M-18.7M-56.7M-55.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.2M38.5M44.1M51.4M
 
 
 
 
 
Shares To Calculate EPS Diluted8.2M38.5M44.1M51.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.12-$0.49-$1.29-$1.08
 
 
 
 
 
EPS Diluted-$2.12-$0.49-$1.29-$1.08